In Vivo Contract Research Organization Market Size Reaches $5.68 Billion In 2026: What Is Driving Growth?

In Vivo Contract Research Organization Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

In Vivo Contract Research Organization Market Poised To Hit $7.77 Billion By 2030 With A 8.1% CAGR

The in vivo contract research organization market has experienced robust expansion in recent years. Its valuation is set to rise from $5.23 billion in 2025 to $5.68 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.6%. The growth observed historically is linked to factors such as increasing pharmaceutical R&D expenditure, the enlargement of biotechnology pipelines, the escalating intricacy of drug development processes, more stringent regulatory mandates for preclinical data, and the accessibility of advanced animal models.

The in vivo contract research organization market is projected to experience substantial expansion in the coming years, reaching a valuation of $7.77 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.1%. This anticipated growth during the forecast period stems from factors such as the heightened need for quicker drug development timelines, the increasing application of sophisticated in vivo disease models, the expansion of research into oncology and rare diseases, the growing integration of AI-enabled preclinical analytics, and stricter regulatory oversight of safety data. Key trends expected over this period involve a rise in the outsourcing of preclinical research activities, a growing requirement for specialized disease models, the wider adoption of GLP-compliant toxicology studies, the broadening of integrated preclinical service offerings, and a greater emphasis on ensuring data quality and reproducibility.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=50560688&type=smp&name=In%20Vivo%20Contract%20Research%20Organization%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In Vivo Contract Research Organization Market Growth Drivers: What’s Behind The Acceleration?

An increasing emphasis on personalized medicine is anticipated to drive expansion in the in vivo contract research organization market moving ahead. This medical strategy involves customizing treatment and prevention plans based on an individual’s genetic profile, way of life, and surroundings to achieve optimal health results. The heightened attention on personalized medicine stems from the improved accessibility and reduced cost of genomic sequencing technologies. These innovations facilitate more precise detection of genetic mutations, leading to customized therapies that enhance patient results and minimize experimental treatment approaches. Consequently, this rising focus on personalized medicine is boosting demand within the in vivo CRO market, as specialized preclinical studies involving particular animal models are essential for assessing targeted treatments and their impact on unique genetic characteristics. As an example, in February 2024, data from the US-based nonprofit Personalized Medicine Coalition (PMC) revealed that the FDA sanctioned 16 novel personalized treatments in 2023, an increase from six in 2022. For the fourth year running, personalized medicines constituted over one-third of all new drug approvals by the U.S. Food and Drug Administration (FDA). Hence, the increasing emphasis on personalized medicine is a key factor propelling the expansion of the in vivo contract research organization market.

In Vivo Contract Research Organization Market Segment Trends And Revenue Contributors

The in vivo contract research organization market covered in this report is segmented –

1) By Type: Rodent Based, Non-Rodent Based

2) By Type Of Service: Translational And IND-Enabling In Vivo Studies, Preclinical Services, Post-Approval Nonclinical Safety And Mechanistic Studies

3) By Good Laboratory Practice Type: Good Laboratory Practice Toxicology, Non Good Laboratory Practice

4) By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications

5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Government And Regulatory Bodies

Subsegments:

1) By Rodent-Based: Mice Models, Rat Models, Genetically Engineered Rodents, Immunodeficient Rodents, Humanized Rodents

2) By Non-Rodent-Based: Canine Models, Non-Human Primate Models, Swine Models, Rabbit Models, Zebrafish Models

In Vivo Contract Research Organization Market Trends: What’s Defining The Industry’s Next Phase?

Leading companies within the in vivo contract research organization market are concentrating on developing innovative solutions, such as advanced therapy incubator programs, to accelerate the progression of next-generation therapeutics and bolster early-stage clinical investigations. An advanced therapy incubator program represents a specialized initiative crafted to assist early-stage biotechnology enterprises by supplying resources, mentorship, and infrastructure, thereby speeding up the development of advanced therapies like gene, cell, and RNA-based treatments. For instance, in April 2025, Charles River Laboratories International Inc., a US-based pharmaceutical firm, launched its initial advanced therapy incubator program cohort. This innovative endeavor is structured to aid early-stage biotech companies focusing on the creation of next-generation therapies. Through this program, participants gain access to Charles River’s scientific knowledge, cutting-edge laboratory infrastructure, and customized in vivo models, empowering them to rapidly generate proof-of-concept data. The program further establishes a realistic preclinical environment for validating therapeutic candidates, contributing to a reduced time-to-clinic and an improved likelihood of regulatory success. By bridging the gap between academic innovation and clinical advancement, this initiative plays a crucial role in propelling the field of advanced therapies forward.

In Vivo Contract Research Organization Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the in vivo contract research organization market are Thermo Fisher Scientific Inc, Labcorp Drug Development Inc, Eurofins Scientific SE, WuXi AppTec, Charles River Laboratories International Inc, Evotec SE, GemPharmatech Co Ltd, BIOQUAL Inc, Crown Bioscience Inc, PsychoGenics Inc, Janvier Labs SAS, Taconic Bioscience Inc, Xentech SAS, Altogen Labs Inc, AniLocus Inc, Pharmaron Beijing Co Ltd, Southern Research Institute, SRI International, Envigo RMS LLC, Horizon Discovery Group plc, Inotiv Inc, GenScript ProBio

View The Full In Vivo Contract Research Organization Market Report:

https://thebusinessresearchcompany.com/report/in-vivo-contract-research-organization-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In Vivo Contract Research Organization Market Regional Analysis: Which Geography Leads On Revenue?

North America was the largest region in the in vivo contract research organization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model